ESG

LOTTE Biologics aims to enrich people’s lives
through our capabilities.

ESG Declaration Statement

LOTTE BIOLOGICS aims to enrich people’s lives through our technology.
We will contribute to improving human health through science-based innovation and embrace our responsibility as a global
company by establishing a sustainable ecosystem.

From our customers, shareholders, employees, suppliers, and to our local communities, we will integrate social and environmental
initiatives in the course of all our business activities.

Through this, we will achieve our vision of Delivering Excellence for a Sustainable World.

August 30th, 2023LOTTE Biologics

2030 Sustainability Management Roadmap

Since its 2023 ESG declaration, LOTTE Biologics has formalized policies on human rights, environment, safety, health, and ethics

2026~2030 implementing global standard ESG standards through advancing carbon neutrality, expanding renewable energy and promoting
biodiversity conservation

Our 2030 Mid- to Long-Term
Sustainability Strategy

Environmental

Carbon Management

  • Establish Net Zero roadmap aligned with LOTTE Group
  • Define Scope 1–3 and implement LCA/PCF-based management

Energy Transition

  • Optimize hydropower portfolio at LBA
  • Expand solar energy and eco-friendly energy use at LBK

Nature & Certifications

  • Disclose water risk (CDP Water)
  • Conduct biodiversity assessment (TNFD)
Social

Supply Chain Resilience

  • Strengthen Partner Code of Conduct (PCOC) compliance
  • Integrate ESG evaluation into procurement processes

Human Rights

  • Join and comply with UN Global Compact
  • Conduct human rights due diligence and remediation processes

Health, Safety & DEI

  • Strengthen occupational health & safety (ISO 45001)
  • Promote diversity, equity, and inclusion across global workforce
Governance

Governance Structure

  • Establish Board-level ESG committee
  • Manage enterprise and operational risks

Business Continuity

  • Implement ISO-based Business Continuity Management System
  • Ensure stable supply of critical medicines

Ethics & Compliance

  • Promote anti-bribery, compliance, and information security certifications
  • Strengthen global ethics standards and protect customer IP

Sustainability Report

2026 Sustainability ReportEnglish PDFKorean PDF

ESG Library

LOTTE Biologics Human Rights CharterEnglish PDFKorean PDF
LOTTE Biologics Environment, Health & Safety PolicyEnglish PDFKorean PDF
LOTTE Biologics Environmental Management PolicyEnglish PDFKorean PDF

Certifications

ISO 45001

Safety & Health Management System

Download